ASCO 2025 Highlights

Podcast | English | 2025 | 55 Min

Create Account

Cost

$0.00

Credit

No Credit Offered

This episode of Lung Cancer Considered reviews important lung cancer data presented at ASCO 2025. Lung Cancer Considered hosts Dr. Narjust Florez and Dr. Stephen Liu are joined by Dr. Charu Aggarwal and Dr. Patrick Forde to discuss several of the most significant lung cancer trials presented at ASCO, including the CheckMate 816, the phase III HERTHENA-Lung02 study, the NEOADAURA study, the REZILIENT1 study, the SWOG Pragmatica study, the IMforte study and the SOHO-01 trial.

Podcast Hosts:

Narjust Florez, MD, Associate Director of the Cancer Care Equity Program and Thoracic Medical Oncologist, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School, Boston, MA, USA
Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., USA

Podcast Guests:

Charu Aggarwal, MD, MPH, Leslye M. Heisler Associate Professor for Lung Cancer Excellence, University of Pennsylvania, Philadelphia, PA, USA
Patrick Forde, MD, MBBCh, Director of Thoracic Oncology - Clinical Research Program and Associate Professor, Johns Hopkins University, Baltimore, MD, USA